A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Clinical trial NCT06603571 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06603571
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-20
- Primary completion
- 2026-07-01
- Enrollment
- 367
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.